Nxera Pharma Co., Ltd. (4565.T) JPX

838.00

+19(+2.32%)

Updated at December 05 03:30PM

Currency In JPY

Valuation

Market Cap94.03B
Enterprise Value129.66B
P/E Ratio-23.08
PEG Ratio0.57
Price/Sales Ratio2.43
Price/Book Ratio1.15
Enterprise/Revenue3.45
Enterprise/EBITDA243.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.1
Operating Margin-0.15

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue28.84B
Revenue/Share346.36
Gross Profit21.22B
EBITDA105M
Net Income-4.84B
Diluted EPS-53.92

Balance Sheet

Total Cash33B
Total Cash/Share366.21
Total Debt64.72B
Total Debt/Equity0.98
Current Ratio3.62
Book Value Per Share730.94

Price History

52-Week Change-22.76
52-Week High1,152
52-Week Low668
Moving Average 50 Days908.08
Moving Average 200 Days894.16

Statistics

Average Volume752,746
Shares Outstanding90.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor4:1
Last Split DateJune 27, 2018